Professor Rob Howard (UCL Psychiatry) said company claims that a new Alzheimer’s treatment was improving cognition in patients “at the very least is implausible… Generally, in this area, we would regard slowing or stopping of cognitive decline as a win.”
Read: New York Times (£)
Close
